4-(4-{3-[4-(3,4-Dimethoxy-phenylamino)-6-methoxy-quinazolin-7-yloxy]-propoxy}-phenyl)-[1,2]dithiole-3-thione

ID: ALA4787657

Chembl Id: CHEMBL4787657

PubChem CID: 162668052

Max Phase: Preclinical

Molecular Formula: C29H27N3O5S3

Molecular Weight: 593.75

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Nc2ncnc3cc(OCCCOc4ccc(-c5cssc5=S)cc4)c(OC)cc23)cc1OC

Standard InChI:  InChI=1S/C29H27N3O5S3/c1-33-24-10-7-19(13-25(24)34-2)32-28-21-14-26(35-3)27(15-23(21)30-17-31-28)37-12-4-11-36-20-8-5-18(6-9-20)22-16-39-40-29(22)38/h5-10,13-17H,4,11-12H2,1-3H3,(H,30,31,32)

Standard InChI Key:  YGVJUDRLYCMUSE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4787657

    ---

Associated Targets(Human)

EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Egfr Epidermal growth factor receptor erbB1 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 593.75Molecular Weight (Monoisotopic): 593.1113AlogP: 7.77#Rotatable Bonds: 12
Polar Surface Area: 83.96Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 3HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.66CX LogP: 6.30CX LogD: 6.30
Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.09Np Likeness Score: -0.65

References

1. Zheng YG,Zhang WQ,Meng L,Wu XQ,Zhang L,An L,Li CL,Gao CY,Xu L,Liu Y.  (2020)  Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (HS) donors as potent EGFR inhibitors against L858R resistance mutation.,  202  [PMID:32619886] [10.1016/j.ejmech.2020.112522]

Source